Long-term Effects of Losartan on Proteinuria and Renal Function in Patients with Renal Amyloidosis

Abstract

Losartan seemed to prevent an increase in proteinuria without altering the creatinine clearance level in patients with amyloidosis type AA during a 12-month period. This indicates that losartan may be used to decrease proteinuria in this patient group. However, our results are only preliminary and need to be confirmed by larger studies.